HM Payson & Co’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $694K | Buy |
6,875
+98
| +1% | +$9.89K | 0.01% | 248 |
|
|
2024
Q4 | $605K | Sell |
6,777
-6
| -0.1% | -$536 | 0.01% | 263 |
|
|
2024
Q3 | $568K | Buy |
6,783
+30
| +0.4% | +$2.51K | 0.01% | 273 |
|
|
2024
Q2 | $520K | Hold |
6,753
| – | – | 0.01% | 268 |
|
|
2024
Q1 | $463K | Buy |
6,753
+83
| +1% | +$5.69K | 0.01% | 291 |
|
|
2023
Q4 | $386K | Sell |
6,670
-936
| -12% | -$54.1K | 0.01% | 304 |
|
|
2023
Q3 | $402K | Buy |
7,606
+2,236
| +42% | +$118K | 0.01% | 289 |
|
|
2023
Q2 | $290K | Sell |
5,370
-150
| -3% | -$8.11K | 0.01% | 320 |
|
|
2023
Q1 | $276K | Buy |
5,520
+4,286
| +347% | +$214K | 0.01% | 320 |
|
|
2022
Q4 | $57.1K | Sell |
1,234
-55
| -4% | -$2.55K | ﹤0.01% | 539 |
|
|
2022
Q3 | $50K | Buy |
1,289
+88
| +7% | +$3.41K | ﹤0.01% | 572 |
|
|
2022
Q2 | $45K | Sell |
1,201
-32
| -3% | -$1.2K | ﹤0.01% | 593 |
|
|
2022
Q1 | $55K | Buy |
1,233
+33
| +3% | +$1.47K | ﹤0.01% | 579 |
|
|
2021
Q4 | $51K | Hold |
1,200
| – | – | ﹤0.01% | 600 |
|
|
2021
Q3 | $52K | Hold |
1,200
| – | – | ﹤0.01% | 584 |
|
|
2021
Q2 | $51K | Hold |
1,200
| – | – | ﹤0.01% | 579 |
|
|
2021
Q1 | $46K | Hold |
1,200
| – | – | ﹤0.01% | 617 |
|
|
2020
Q4 | $43K | Buy |
1,200
+150
| +14% | +$5.38K | ﹤0.01% | 624 |
|
|
2020
Q3 | $40K | Hold |
1,050
| – | – | ﹤0.01% | 599 |
|
|
2020
Q2 | $37K | Buy |
1,050
+250
| +31% | +$8.81K | ﹤0.01% | 559 |
|
|
2020
Q1 | $26K | Sell |
800
-274
| -26% | -$8.91K | ﹤0.01% | 593 |
|
|
2019
Q4 | $49K | Sell |
1,074
-225
| -17% | -$10.3K | ﹤0.01% | 596 |
|
|
2019
Q3 | $53K | Hold |
1,299
| – | – | ﹤0.01% | 586 |
|
|
2019
Q2 | $56K | Buy |
+1,299
| New | +$56K | ﹤0.01% | 581 |
|